BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 36246388)

  • 21. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
    Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
    Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application Progress of Organoids in Colorectal Cancer.
    Luo L; Ma Y; Zheng Y; Su J; Huang G
    Front Cell Dev Biol; 2022; 10():815067. PubMed ID: 35273961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research.
    Yan S; He Y; Zhu Y; Ye W; Chen Y; Zhu C; Zhan F; Ma Z
    Front Cell Dev Biol; 2024; 12():1384450. PubMed ID: 38638528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine.
    Yang Y; Kong Y; Cui J; Hou Y; Gu Z; Ma C
    Stem Cell Rev Rep; 2024 Mar; ():. PubMed ID: 38532032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer].
    Wang HW; Ma XQ; Gao S; Hao JH
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(7):710-713. PubMed ID: 38808439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of organoids in precision immunotherapy of lung cancer (Review).
    Tian H; Ren J; Mou R; Jia Y
    Oncol Lett; 2023 Nov; 26(5):484. PubMed ID: 37818130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D Cell Cultures: Evolution of an Ancient Tool for New Applications.
    Cacciamali A; Villa R; Dotti S
    Front Physiol; 2022; 13():836480. PubMed ID: 35936888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organoids: Past Learning and Future Directions.
    O'Connell L; Winter DC
    Stem Cells Dev; 2020 Mar; 29(5):281-289. PubMed ID: 31805828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
    Pauli C; Moch H; Rubin MA
    Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To Better Generate Organoids, What Can We Learn From Teratomas?
    Li H; Gao L; Du J; Ma T; Ye Z; Li Z
    Front Cell Dev Biol; 2021; 9():700482. PubMed ID: 34336851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flourishing tumor organoids: History, emerging technology, and application.
    Yang Q; Li M; Yang X; Xiao Z; Tong X; Tuerdi A; Li S; Lei L
    Bioeng Transl Med; 2023 Sep; 8(5):e10559. PubMed ID: 37693042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Organoid as a Drug Screening Platform for Cancer Research.
    Mahbubi R; Yousefi N; Hamidieh AA; Gholizadeh F; Sisakht MM
    Curr Stem Cell Res Ther; 2023 Oct; ():. PubMed ID: 37855289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of meningioma patient-derived organoid.
    Chan HSC; Ng HK; Chan AK; Cheng SH; Chow C; Wong N; Wong GKC
    J Clin Neurosci; 2021 Dec; 94():192-199. PubMed ID: 34863437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioengineered Tumor Organoids.
    Dominijanni A; Mazzocchi A; Shelkey E; Forsythe S; Devarsetty M; Soker S
    Curr Opin Biomed Eng; 2020 Mar; 13():168-173. PubMed ID: 32432209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-on-a-chip for Drug Screening.
    Lee IC
    Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug screening model meets cancer organoid technology.
    Liu C; Qin T; Huang Y; Li Y; Chen G; Sun C
    Transl Oncol; 2020 Nov; 13(11):100840. PubMed ID: 32822897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.